- Home
- ZBIO vs PCYO Comparison
ZBIO vs PCYO Comparison
Compare ZBIO & PCYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZBIO
- PCYO
- Stock Information
- Founded
- ZBIO 2019
- PCYO 1976
- Country
- ZBIO United States
- PCYO United States
- Employees
- ZBIO N/A
- PCYO N/A
- Industry
- ZBIO
- PCYO Water Supply
- Sector
- ZBIO
- PCYO Utilities
- Exchange
- ZBIO NYSE
- PCYO Nasdaq
- Market Cap
- ZBIO 268.7M
- PCYO 271.7M
- IPO Year
- ZBIO 2024
- PCYO N/A
- Fundamental
- Price
- ZBIO $7.83
- PCYO $11.49
- Analyst Decision
- ZBIO Strong Buy
- PCYO
- Analyst Count
- ZBIO 6
- PCYO 0
- Target Price
- ZBIO $29.20
- PCYO N/A
- AVG Volume (30 Days)
- ZBIO 207.0K
- PCYO 35.5K
- Earning Date
- ZBIO 03-04-2025
- PCYO 04-09-2025
- Dividend Yield
- ZBIO N/A
- PCYO N/A
- EPS Growth
- ZBIO N/A
- PCYO 103.72
- EPS
- ZBIO N/A
- PCYO 0.55
- Revenue
- ZBIO N/A
- PCYO $29,113,000.00
- Revenue This Year
- ZBIO N/A
- PCYO N/A
- Revenue Next Year
- ZBIO N/A
- PCYO N/A
- P/E Ratio
- ZBIO N/A
- PCYO $20.89
- Revenue Growth
- ZBIO N/A
- PCYO 56.25
- 52 Week Low
- ZBIO $5.83
- PCYO $8.94
- 52 Week High
- ZBIO $26.25
- PCYO $14.63
- Technical
- Relative Strength Index (RSI)
- ZBIO N/A
- PCYO 43.48
- Support Level
- ZBIO N/A
- PCYO $11.23
- Resistance Level
- ZBIO N/A
- PCYO $12.25
- Average True Range (ATR)
- ZBIO 0.00
- PCYO 0.28
- MACD
- ZBIO 0.00
- PCYO 0.03
- Stochastic Oscillator
- ZBIO 0.00
- PCYO 25.49
About ZBIO ZENAS BIOPHARMA INC
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.
About PCYO Pure Cycle Corporation
Pure Cycle Corp is a diversified land and water resource development company. It designs, constructs, manages, operates, and maintains water and wastewater systems. The firm operates in two business segments namely Water and wastewater resource development and Land development. It generates maximum revenue from the Land development segment. The company's services include water production, storage, treatment, bulk transmission to retail distribution systems, wastewater collection and treatment, irrigation water treatment and transmission, construction management, billing, and collection. The land resource development segment includes all the activities necessary to develop and sell finished lots.